HCB101 with ramucirumab and paclitaxel as a CD47–SIRPα innate immune combination strategy in previously treated advanced gastric/GEJ cancer (ESMO Asia 2026) - Oct 1, 2026 - Abstract #1066P; Pres time: Dec 4, 2026; 05:15 PM - 06:15 PM; Location: Poster area (Exhibition); No abstract available
Metastases • Gastric Cancer • Oncology • SIRPA
|
|
Fangling Ning; Guohua Chen; Yuping Sun; Jingtang Chen; Hongyu Zhang; Lili Chen; Zhili Zhou; Fei Mo; Abigail Yu; Wei Ji; Alvin Luk
|